Abstract
Rationale: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are widely used for the treatment of EGFR mutation positive advan......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
